Fig. 3From: Impaired B cell immunity in acute myeloid leukemia patients after chemotherapyGreater frequencies of transitional B-cells and dramatically fewer memory B-cells in AML patients at baseline. a Frequencies of total CD19+ B-cells, naïve B-cells, and transitional B-cells in HD and AML at baseline and day 30. b Frequencies of total memory, IgA+, and IgG+ B-cells in HD and AML at baseline. AML patients indicated in figure key. c Proportions of transitional, naïve, and memory B-cells (top pie charts) and proportions of resting memory, altered memory, and activated memory B-cells (bottom pie charts) in HD and AML at baselineBack to article page